Key result
Pre-CPB arterial ANF levels were significantly higher in mitral stenosis patients compared to coronary artery disease patients (243 vs 29 pg/ml, P<0.01), and decreased rapidly during CPB.
Why the study?
How does cardiopulmonary bypass affect the time-course of atrial natriuretic factor (ANF) release in patients with mitral stenosis versus coronary artery disease?
Observational (n=14)
How does cardiopulmonary bypass affect the time-course of atrial natriuretic factor (ANF) release in patients with mitral stenosis versus coronary artery disease?
Absolute Event Rate: 243% vs 29%
p-value: p=<0.01
Atrial natriuretic factor release during cardiopulmonary bypass is highly dependent on atrial filling pressure, demonstrating markedly different baseline levels and dynamic responses in patients with mitral stenosis compared to those with coronary artery disease.
ANF dynamics during CPB vary by pathology; observational data leave open any role for ANF monitoring in mitral valve surgery.
We determined the time-course of the release of atrial natriuretic factor (ANF) during cardiopulmonary bypass (CPB) in six patients undergoing coronary artery bypass (CAD) and eight patients undergoing valve replacement for mitral stenosis (MS). Before CPB, the arterial ANF was significantly higher in MS patients than in CAD patients (243 +/- 38 and 29 +/- 5.8 pg/ml respectively, P less than 0.01). With the onset of CPB, the acute pressure unloading of the atria induced a significant, rapid decrease of ANF only in MS patients (-64% of pre-CPB value at 5 min) and no major changes in CAD patients. Clamping of the aorta induced a further progressive reduction of ANF release to almost zero in both groups. Readmission of coronary flow to the empty atria with declamping resulted in an increase in the plasma level of ANF in both groups to reach the concentration present in MS patients before CPB. After CPB, the ANF levels decreased in CAD patients while remaining elevated in MS patients. These data suggest that ANF release from human atria depends on atrial filling pressure and other unknown factors.
No takes yet. Share an insight, caveat, or question.
Curello et al. (1991) conducted an observational in Coronary artery disease and mitral stenosis (n=14). Mitral stenosis vs. Coronary artery disease was evaluated on Pre-CPB arterial ANF levels (pg/ml) (p=<0.01). Pre-CPB arterial ANF levels were significantly higher in mitral stenosis patients compared to coronary artery disease patients (243 vs 29 pg/ml, P<0.01), and decreased rapidly during CPB.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: